Senators owner Eugene Melnyk appeared on the Canadian Business News Network (BNN) today to discuss the legitimacy and policing (or lack thereof) of corporate tax inversion strategies used by publicly traded companies. While the better part of the interview was spent characterizing his Valeant Pharmaceuticals Inc. (the new name of his former company Biovail Corp.) as a “house of cards”, Melnyk was eventually posed a question pertaining to his ownership of the Ottawa Senators.
Not even during a BNN interview could Melnyk avoid a question pertaining to where he envisions the Senators finishing in the standings and whether he will spend more money on players in the near future.
“I made a point, I said after this coming season, I said, ‘A) I’m not going to talk to talk about money unless you want to buy the team.’ But in all seriousness, the team is doing very, very, very well. We now have a great group of players. They are all motivated. They’re all like, they feel like little underdogs, but they’re going to go in… we’ve got a bigger team. A tougher team. I think we’re going to do very well. I think everybody is focused on getting into the playoffs this year, so I think we’ll do just fine, thanks.”